All articles by Alan Booth – Page 2
-
Industry newsGlobal life sciences consultancy created from SSI/NDA merger
US-based SSI Strategy buys Sweden-based regulatory affairs consultancy NDA Group AB; Strömquist stays on as President of NDA unit.
-
Industry newsRapid COVID-19 breath test device shows promise
A small, COVID-19 breath test device – developed by researchers from Washington University, St. Louis– can detect the SARS-CoV-2 virus.
-
Industry newsPatient groups get pharma funding; often petition NICE
An investigation by The Observer reveals how patient groups receiving funding from pharma often petition NICE for NHS approvals.
-
VideoEuropean Parliament gives first stage approval for revised EMA fees
MEPs in Strasbourg follow the parliament’s health committee’s approval of report to revise how EMA charges.
-
Industry newsAI-enabled imaging cuts serious stroke diagnosis times
Med-Tech Innovation Conference keynote ‘fireside chat’: Dr Paul Bhogal, Royal London Hospital and Gianluca Casali, Johnson & Johnson.
-
Industry newsNeuralink gets FDA approval for its first brain device trials
Elon Musk’s Neuralink receives FDA approval to conduct a first clinical trial in humans of its experimental brain-computer interface ‘The Link’.
-
Industry newsIllegal vapes found to contain lead and nickel: TOPRA Fellow
Inter Scientific - founded by TOPRA Fellow David Lawson - tests vapes confiscated from school children as part of BBC News investigation.
-
Industry newsChanging of the guard at Regulatory Rapporteur
Leslie Dowling, Editor-in-Chief of the Regulatory Rapporteur, for 12 years steps down:
Davina Stevenson set to take on lead of respected journal. -
Industry newsWHO says COVID-19 ‘no longer a global health emergency’
SARS-Cov-2 – which caused the COVID-19 pandemic – “no longer a public health emergency of international concern”: WHO.
-
Industry newsIndia backs ambitious expansion in spending to support medical devices
India’s seeks to cut its dependence on imports of medical devices.
-
Industry newsGhana approves R21 malaria vaccine; first to exceed WHO’s efficacy target
The vaccine will be called Matrix-M™
-
Commentary‘Science is more than
a body of knowledge’How the Regulatory Rapporteur’s online platform will provide its online journal experience
- Previous Page
- Page1
- Page2
- Next Page